Evidence for Control of Synthesis of the Variable Regions of the Heavy Chains of Immunoglobulins G and M by the Same Gene*

  1. A. C. Wang,
  2. S. K. Wilson,
  3. J. E. Hopper§,
  4. H. H. Fudenberg, and
  5. A. Nisonoff
  1. DEPARTMENT OF MEDICINE, UNIVERSITY OF CALIFORNIA MEDICAL CENTER, SAN FRANCISCO
  2. THE DEPARTMENT OF SURGERY, UNIVERSITY OF ILLINOIS MEDICAL CENTER, CHICAGO, ILLINOIS
  3. THE DEPARTMENT OF BIOLOGICAL CHEMISTRY, UNIVERSITY OF ILLINOIS MEDICAL CENTER, CHICAGO, ILLINOIS

Abstract

Previous work indicated that the light chains of a monotypic immunoglobulins G2-K and M-K from a single patient (Ti1) are identical. Our present data show that the monotypic immunoglobulins G and M share idiotypic determinants not present in their isolated light chains or in any of a large number of other immunoglobulins tested, and that amino acid sequences of the first 27 residues from the NH2-terminal end of the γ- and μ-chains are identical. These results support the hypothesis that at least two genes control the synthesis of each heavy and light chain and suggest that the monotypic immunoglobulin G and monotypic immunoglobulin M of this patient share three of the four genes involved. It is proposed that, during normal immunoglobulin synthesis, different cells of a single clone synthesize immunoglobulins M and G, and that the light chains and the variable segments of the heavy chains of the proteins of the two classes are identical within the clone. A genetic switching mechanism is suggested.

Footnotes

  • Recipient of an American Cancer Society postdoctoral fellowship. Requests for reprints should be sent to Dr. Wang, Department of Medicine, University of California Medical Center, San Francisco, California 94122.

  • Recipient of a special postdoctoral fellowship of the National Institutes of Health.

  • § Recipient of a postdoctoral fellowship of the National Institutes of Health.

  • * Supported by grants from the National Institutes of Health (AI-06281 and AI-09145); National Science Foundation (GB-5424); the Cancer Research Coordinating Committee of the University of California; the Jane Coffin Childs Foundation; and the American Cancer Society.

« Previous | Next Article »Table of Contents